This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

GNC Rises After Upgrade, Vitamin Shoppe Seen as Potential Partner

Stocks in this article: GNC

NEW YORK (TheStreet) -- Shares of health and wellness product retailer GNC Holdings (GNC) are rising in early trading after analysts at Credit Suisse upgraded the stock. Additionally, the research firm said it remains "intrigued" about the potential for a merger between the company and its peer Vitamin Shoppe (VSI).

WHAT'S NEW: In a note to investors this morning, Credit Suisse analysts Gary Balter and Andrew Kinder increased their rating on GNC shares to Outperform from Neutral, citing confidence in the company's CEO, Michael Archbold, and the stock's recent underperformance following earnings misses in its last three consecutive quarters. The analysts contend that GNC has a loyal customer base and that some changes to its cost base, store count and franchise terms could lead it to better results. Credit Suisse maintained its $43 price target on shares of GNC.

WHAT'S NOTABLE: The analysts also stated that they "remain intrigued" by the potential for a merger between GNC and its rival Vitamin Shoppe. The two companies have a high degree of store overlap and Vitamin Shoppe would get the sports nutrition and manufacturing operations that it is "currently chasing through dilutive investments" by combining with GNC, the analysts wrote. The research note also pointed out that Archbold, who was appointed GNC's CEO just last week, previously served as the Chief Operating Officer and as the Chief Financial Officer of Vitamin Shoppe and that he has a "rich history with private equity funds."

PRICE ACTION: Shares of GNC Holdings rose $1.31, or 4.01%, to $33.98 in mid-morning trading, while Vitamin Shoppe gained $1.06, or 2.82%, to $38.61.

Reporting by Jason Keil.

The Fly provides comprehensive coverage of stock news and Street research and delivers it in real-time. The Fly breaks market-moving news and explains sudden stock movements in a rapid-fire, short-form story format. Follow @theflynews on Twitter. For a free trial, click here.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,828.24 +0.49 0.00%
S&P 500 2,067.56 -5.27 -0.25%
NASDAQ 4,791.63 +4.3130 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs